Yüklüyor......

Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments

Evolving intensiveness of colorectal cancer (CRC) treatment, including chemotherapeutics and targeted agents associations, in adjuvant and metastatic CRC (MCRC) settings, increased overall survival (OS) with individual variability of toxicity. Pharmacogenomic guidelines recommended pre-treatment ide...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmgenomics Pers Med
Asıl Yazarlar: Bruera, Gemma, Ricevuto, Enrico
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7678498/
https://ncbi.nlm.nih.gov/pubmed/33235483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S253586
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!